Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,363 | -1,880 | -998 | -4,407 | -3,146 |
| Depreciation Amortization | 840 | 559 | 280 | 1,120 | 840 |
| Accounts receivable | 128 | N/A | N/A | -128 | N/A |
| Accounts payable and accrued liabilities | 169 | 154 | 191 | 293 | -63 |
| Other Working Capital | 599 | 454 | 236 | 436 | -112 |
| Other Operating Activity | -5,967 | -154 | -191 | -165 | 63 |
| Operating Cash Flow | $-1,868 | $-867 | $-482 | $-2,851 | $-2,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -18 | -18 |
| Other Investing Activity | 2 | 1 | 0 | 3 | 2 |
| Investing Cash Flow | $2 | $1 | $N/A | $-15 | $-16 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 807 | 867 | 483 | 2,865 | 2,633 |
| Common Stock Issued | 3,726 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $4,533 | $867 | $483 | $2,865 | $2,633 |
| Beginning Cash Position | 1 | 1 | 1 | 2 | 2 |
| End Cash Position | 2,668 | 2 | 2 | 1 | 201 |
| Net Cash Flow | $2,667 | $1 | $1 | $-1 | $199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,868 | -867 | -482 | -2,851 | -2,418 |
| Capital Expenditure | N/A | N/A | N/A | -18 | -18 |
| Free Cash Flow | -1,868 | -867 | -482 | -2,869 | -2,436 |